Spatially Addressable Polymerase Control for Parallel Sequence Synthesis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Enzymatic polynucleotide synthesis using template-independent polymerases lacks precise control over the base-by-base sequence of polynucleotides, leading to unregulated nucleotide addition and the formation of variable length homopolymers, which is a challenge for applications requiring high-throughput synthesis of multiple polynucleotides with different sequences.

Innovation Solution

Spatially addressable control of polymerase activity on an array surface is achieved by regulating the activity of template-independent polymerases using blocking groups, pH changes, or enzyme inhibitors, allowing for independent control of polymerase activity at specific locations on the array.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If template-independent polymerase is used for enzymatic polynucleotide synthesis, then the synthesis can be performed in an aqueous environment without toxic organic chemicals, but the polymerase adds nucleotides in an unregulated manner creating random sequences or variable length homopolymers

Engineering Contradiction:
Improvetoxic organic chemicalsVSAvoidbase-by-base sequence control
Core Design Contradiction:
Object-affected harmful factorsVSManufacturing precision

Solution Approach 1:

The polymerase population is segmented into two distinct functional components: a template-independent polymerase for nucleotide addition and a template-dependent polymerase for sequence control. This segmentation allows each polymerase type to perform its specialized function without interference, resolving the contradiction between unregulated addition and precise sequence control

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A template DNA strand acts as an intermediary that translates the desired sequence information into controlled nucleotide incorporation. The template-dependent polymerase uses this intermediary to ensure that only the correct nucleotide is added at each position, providing base-by-base sequence precision while maintaining aqueous synthesis conditions

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If only a single species of nucleotide is present in the reaction, then the polymerase can add nucleotides continuously, but this creates variable length homopolymers instead of controlled sequences

Engineering Contradiction:
Improvenucleotide addition rateVSAvoidsequence specificity
Core Design Contradiction:
ProductivityVSManufacturing precision

Solution Approach 1:

The system dynamically switches between different nucleotide species based on the template sequence requirements. The template-dependent polymerase dynamically selects which nucleotide to incorporate at each position, allowing continuous productive synthesis while maintaining precise sequence control through template-directed recognition

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The template DNA provides continuous feedback to the template-dependent polymerase about which nucleotide should be added next. This feedback mechanism ensures that nucleotide addition continues at high productivity while maintaining sequence specificity, as the polymerase adjusts its substrate selection based on template complementarity

Inventive Principle:
Principle #23Feedback

3Productivity

If polymerase activity is activated at multiple locations on the array simultaneously, then parallel synthesis can be performed, but it is impossible to synthesize polynucleotides with different sequences on the same array

Engineering Contradiction:
Improveparallel synthesis throughputVSAvoidsequence diversity on array
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

Different regions of the array are assigned different template DNA sequences, creating local quality variations. Each location's template directs the template-dependent polymerase to incorporate specific nucleotides in a sequence-specific manner, enabling parallel synthesis of multiple different polynucleotide sequences simultaneously across the array

Inventive Principle:
Principle #3Local quality

4Manufacturing precision

If the nucleoside phosphoramidite method is used, then each synthesis cycle reliably adds a single specific nucleotide, but the method uses toxic organic chemicals and requires complex chemical reactions

Engineering Contradiction:
Improvenucleotide addition controlVSAvoidtoxic organic chemicals
Core Design Contradiction:
Manufacturing precisionVSObject-affected harmful factors

Solution Approach 1:

The complex chemical reaction system of the phosphoramidite method is replaced with a biological enzyme system. Template-dependent polymerases naturally perform sequence-specific nucleotide incorporation through biochemical recognition mechanisms, achieving the same precision without toxic organic chemicals or complex chemical activation steps

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the parallel synthesis of polynucleotides with different sequences on the same array, improving scalability and throughput by confining polymerase activity to selected locations, thereby overcoming the limitations of unregulated synthesis.

Implementation Method 1

The blocking group sterically hinders access to the active site on the polymerase preventing activity

Methodology Applied
Scientific EffectSteric hindrance:

Implementation Method 2

His-tags are complexed to a ligand on the blocking group with divalent metal cations such as Cu2+

Methodology Applied
Scientific EffectMetal cation complexation:

Implementation Method 3

Changing the oxidation state of the metal cation from 2+ breaks the His-tag complex and releases the blocking group from the template-independent polymerase

Methodology Applied
Scientific EffectRedox reactions: Redox Reactions

Implementation Method 4

The oxidation state of the metal cation may be changed by redox reactions initiated through electrodes

Methodology Applied
Scientific EffectElectrochemical redox:

Implementation Method 5

The pH of the solution at a selected location on the surface of the array is changed from the unsuitable pH to an optimum pH for the polymerase

Methodology Applied
Scientific EffectpH change:

Implementation Method 6

The pH of the solution may be changed by activation of electrodes, addition of an acid or base, or photoactivation of a photoacid or a photobase

Methodology Applied
Scientific EffectPhotoactivation: Photo-oxidation

Implementation Method 7

The change in pH is confined to the selected location by a buffer in a reaction reagent solution

Methodology Applied
Scientific EffectBuffering:

Data Source

PatentUS20250283136A1Spatially addressable control of polymerase activity
Publication Date: 2025.09.11 MICROSOFT TECHNOLOGY LICENSING LLC
  • US20250283136A1 patent drawing
  • US20250283136A1 patent drawing
  • US20250283136A1 patent drawing

AI summary

Multiple polynucleotides having different, arbitrary sequences are synthesized on the surface of an array by spatial control of polymerase activity. The polymerase is a template-independent polymerase such as terminal deoxynucleotidyl transferase (TdT). Spatial control of polymerase activity is implemented by localized changes in redox-pH conditions. A single species of nucleotide is added and incorporated on growing polynucleotide strands at locations on the array where the polymerase is active. A washing step removes the polymerase and free nucleotides. This process may be repeated multiple times changing both the location of polymerase activity and the species of nucleotide thereby synthesizing different polynucleotides in parallel on the surface of the array. Polymerase activity may be regulated by removing a blocking group attached to a His-tag sequence on the polymerase, a change in pH, or release of encapsulated inhibitors.